Paper - WANFANG MED ONLINE

You Position: Home > Paper

Progress of research on pathogenesis of diabetic retinopathy

( views:487, downloads:460 )

Author:: No author available

Journal Title:: INTERNATIONAL JOURNAL OF OPHTHALMOLOGY

Issue:: 11

DOI:: No doi available

Key Word:: 糖尿病视网膜病变;发病机制;细胞因子;视网膜

Abstract：糖尿病视网膜病变(diabetic retinopathy,DR)是糖尿病最常见、最主要的微血管并发症之一,已经成为当前全球致盲的重要原因.其基本病理改变是视网膜的血-视网膜屏障的破坏和视网膜新生血管形成,黄斑水肿,最终视网膜脱离,导致失明.高血糖是公认的DR发生和发展的主要危险因素,DR还与多元醇代谢、糖基化终产物、甘油二酯-蛋白激酶C系统、氧化应激和自由基、炎症反应以及细胞因子等有关,但至今其发病机制尚未完全阐明,本文就目前DR的发病机制做一系统性的综述,为DR的治疗提供新的思路.

Reference

[1]黎铧,胡竹林.血管内皮细胞生长因子在糖尿病性视网膜病变进展中的作用[J].2008,(5).
[2]哈文静,严宏.炎症在糖尿病视网膜病变发病机制中的作用[J].2005,(4).
[3]陈雨,朱晓华.糖尿病视网膜病变发病机制的研究进展[J].2006,(2).
[4]张小玲,邱曙东,陈艳炯,等.糖尿病性视网膜病变发病机制研究进展[J].2005,(6).
[5]李娟,胡永华.糖尿病性视网膜病变的易感基因[J].2008,(2).
[6]J L, Wautier,P J, Guillausseau.Advanced glycation end products, their receptors and diabetic angiopathy.[J].2001,27(5 Pt 1).
[7]T T, Lu,L G, Yan,J A, Madri.Integrin engagement mediates tyrosine dephosphorylation on platelet-endothelial cell adhesion molecule 1.[J].1996,93.
[8]A W, Stitt,Y M, Li,T A, Gardiner,etc.Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats.[J].1997,150(2).
[9]Zheng L,Kern TS.Poly(ADP-Ribose) Polymerase Is Involved in the Development of Diabetic Retinopathy via Regulation of Nuclear Factor-{kappa}B.[J].2004,53(11).
[10]Campbell IL,Archer DB,Adamis AP,etc.The role of advanced glycation end products in retinal microvascular leukostasis.[J].2003,44(10).
[11]Gerhardinger C,Sun W,Oates PJ,etc.A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.[J].2006,55(10).
[12]Murata T,Adamis AP,Aiello LP,etc.Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition.[J].1999,96(19).
[13]E, Agardh,B, Hultberg,C, Agardh.Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats.[J].2000,21(1).
[14]Aiello, Lloyd Paul,Avery, Robert L.,Arrigg, Paul G.,etc.Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders.[J].1994,331(22).
[15]Robert N, Frank.Diabetic retinopathy.[J].2004,350(1).
[16]Kumagai AK,Minchenko AG,Vasupuram R,etc.Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats.[J].2003,52(3).
[17]K K, Hirschi,P A, D'Amore.Pericytes in the microvasculature.[J].1996,32.
[18]Morley JE.Diabetes and aging: epidemiologic overview.[J].2008,24(3).
[19]Cooper WL,Ren JG,Cowan MR,etc.Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site[J].2004,101(17).
[20]Akagi Y,Tsuzuki S,Takamura Y,etc.Role of the polyol pathway in high glucose-induced apoptosis of retinal pericytes and proliferation of endothelial cells.[J].2008,49(7).
[21]Gerhardt H,Betsholtz C,Wolburg H,etc.Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis.[J].2001,153(3).
[22]Sahel JA,Tessier LH,Lecleire Collet A,etc.Advanced glycation end products can induce glial reaction and neuronal degeneration in retinal explants.[J].2005,89(12).
[23]Gardner TW,Barber AJ,Hollinger LA,etc.Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors.[J].1999,274(33).
[24]Amrite AC,Kompella UB,Ayalasomayajula SP.Inhibition of cyclooxygenase-2, but not cyclooxygenase-1, reduces prostaglandin E2 secretion from diabetic rat retinas.[J].2004,498(1).
[25]Engerman RL,Kern TS.Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin.[J].2001,50(7).
[26]Gerhardinger C,Asnaghi V,Adeboje A,etc.A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat.[J].2003,52(2).
[27]Lorenzi M,Park YS,Asnaghi V,etc.Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy.[J].2004,53(9).
[28]D W, Dawson,O V, Volpert,P, Gillis,etc.Pigment epithelium-derived factor: a potent inhibitor of angiogenesis.[J].1999,285(5425).
[29].The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus[J].1993.
[30]T S, Kern,J, Tang,M, Mizutani,etc.Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.[J].2000,41(12).
[31]Chakrabarti S,Chen S,Kowluru RA,etc.Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants.[J].2003,37(11).
[32]Kathryn, Haskins,Brenda, Bradley,Katherine, Powers,etc.Oxidative stress in type 1 diabetes.[J].2003,1005.
[33]S E, Bursell,A C, Clermont,B T, Kinsley,etc.Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy.[J].1996,37.
[34]Goldberg H.,Ziyadeh F.,Brownlee M.,etc.Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation[J].2000,97(22).
[35]Treins C,Giorgetti-Peraldi S,Murdaca J,etc.Regulation of vascular endothelial growth factor expression by advanced glycation end products.[J].2001,276(47).
[36]Kowluru RA.Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro conditions.[J].2005,76(9).
[37]Lorenzi M,Boeri D,Maiello M.Increased prevalence of microthromboses in retinal capillaries of diabetic individuals.[J].2001,50(6).
[38]Meyer-Schwickerath R,Pfeiffer A,Blum W F,etc.Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.[J].1993.